Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01139801 · ClinicalTrials.gov registry record · NA
Cervical Ripening for Induction of Labor: Misoprostol Versus Oxytocin in Conjunction With Foley Balloon
A NA study, sponsored by Aultman Health Foundation.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01139801 is a NA study that has completed, run by Aultman Health Foundation. The registered enrollment target is 50 participants.
The verdict
NCT01139801, a NA study, has completed, sponsored by Aultman Health Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to specifically investigate the efficacy of an alternative pharmacologic cervical ripening agent, misoprostol, versus the standard oxytocin, as an adjunct to Foley balloon for induction of the unfavorable cervix.
Interventions
- DRUG Oxytocin
- DRUG Misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01139801
The ClinicalTrials.gov registry entry for NCT01139801 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aultman Health Foundation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oxytocin is the first listed.
NCT01139801 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01139801 about?
NCT01139801 is a clinical study titled "Cervical Ripening for Induction of Labor: Misoprostol Versus Oxytocin in Conjunction With Foley Balloon". The purpose of this study is to specifically investigate the efficacy of an alternative pharmacologic cervical ripening agent, misoprostol, versus the standard oxytocin, as an adjunct to Foley balloon for induction of the unfavorable cervix.
What is the current status of trial NCT01139801?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2009-09. Estimated completion is 2010-03.
What interventions are being tested in trial NCT01139801?
The interventions under investigation include: Oxytocin (DRUG), Misoprostol (DRUG).
Who is sponsoring clinical trial NCT01139801?
This trial is sponsored by Aultman Health Foundation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.